Mathias Bruyand

1.9k citations

35 papers · 1.1k indexed · h-index 19

Co-authors: François Dabis Geneviève Chêne Fabrice Bonnet Henriette de Valk P. Mercié Stéphane Bonacorsi C. Greib D. Neau
Topics: Pneumocystis jirovecii pneumonia detection and treatment (10 papers)HIV/AIDS Research and Interventions (10 papers)HIV Research and Treatment (9 papers)
Cited by: Virology Endocrinology Infectious Diseases
Journals: PLoS ONE Clinical Infectious Diseases Journal of Hepatology
Partner nations: France Denmark United Kingdom

In The Last Decade

Mathias Bruyand

33 papers receiving 1.1k citations

Peers

Countries citing papers authored by Mathias Bruyand

Since Specialization

Citations

This map shows the geographic impact of Mathias Bruyand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Bruyand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Bruyand more than expected).

Fields of papers citing papers by Mathias Bruyand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Bruyand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Bruyand. The network helps show where Mathias Bruyand may publish in the future.

Co-authorship network of co-authors of Mathias Bruyand

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Bruyand. A scholar is included among the top collaborators of Mathias Bruyand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Bruyand. Mathias Bruyand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016 2019 ·Eurosurveillance ·Mathias Bruyand,Patricia Mariani‐Kurkdjian,Simon Le Hello,(unknown),Dieter Van Cauteren,Sophie Lefèvre,Malika Gouali,Nathalie Jourdan‐Da Silva,Alexandra Mailles,(unknown),Estelle Loukiadis,(unknown),Chantal Loirat,Stéphane Bonacorsi,François‐Xavier Weill,Henriette de Valk	47
2	Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups 2018 ·PLoS ONE ·Brecht Ingelbeen,Mathias Bruyand,(unknown),Simon Le Hello,Kostas Danis,Cécile Sommen,Stéphane Bonacorsi,Henriette de Valk	16
3	Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection 2017 ·Médecine et Maladies Infectieuses ·Mathias Bruyand,Patricia Mariani‐Kurkdjian,Malika Gouali,Henriette de Valk,Lisa A. King,Simon Le Hello,Stéphane Bonacorsi,Chantal Loirat	80
4	Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study 2016 ·The Lancet HIV ·Daria Podlekareva,(unknown),Anna Schultze,Frank A. Post,(unknown),(unknown),Hansjakob Furrer,Robert F. Miller,Marcelo H. Losso,Javier Toibaro,José M. Miró,Anna Vassilenko,Enrico Girardi,Mathias Bruyand,Niels Obel,Jens Lundgren,Amanda Mocroft,Ole Kirk	43
5	Public health structures attendance during the Ebola outbreak in Guéckédou, Guinea 2016 ·Epidemiology and Infection ·Frédéric Moisan,(unknown),(unknown),(unknown),(unknown),Thomas Mollet,Mathias Bruyand	6
6	Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients 2015 ·AIDS ·Mathias Bruyand,(unknown),A. Lavolé,Karen Leffondré,Jean Philippe Spano,Vincent Le Moing,(unknown),Laura March,Jacquès Cadranel,Fabrice Bonnet,Marguerite Guiguet	7
7	Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mathias Bruyand,Lene Ryom,Leah Shepherd,Gerd Fätkenheuer,Andrew E. Grulich,Peter Reiss,Stéphane De Wit,Antonella d’Arminio Monforte,Hansjakob Furrer,Christian Pradier,Jens Lundgren,Caroline Sabin	31
8	AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000–2008: hospital-based cohort studies 2014 ·BMC Infectious Diseases ·(unknown),Paula M. Luz,Mathias Bruyand,Sayonara Ribeiro,Fabrice Bonnet,Ronaldo I. Moreira,Mojgan Hessamfar,(unknown),C. Greib,Charles Cazanave,Valdiléa G. Veloso,François Dabis,Beatriz Grinsztejn,Geneviève Chêne	24
9	Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy Failure 2014 ·PLoS ONE ·Marie-Anne Vandenhende,Pantxika Bellecave,Patrícia Recordon-Pinson,Sandrine Reigadas,Yannick Bidet,Mathias Bruyand,Fabrice Bonnet,Estibaliz Lazaro,D. Neau,Hervé Fleury,François Dabis,Philippe Morlat,Bernard Masquelier	35
10	Decline in locomotor functions over time in HIV-infected patients 2014 ·AIDS ·Laura Richert,(unknown),P. Mercié,Frédéric‐Antoine Dauchy,Mathias Bruyand,C. Greib,François Dabis,Fabrice Bonnet,Geneviève Chêne,Patrick Dehail	40
11	Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe 2013 ·European Respiratory Journal ·Daria Podlekareva,(unknown),Daniel Grint,Frank A. Post,José M. Miró,Mathias Bruyand,Hansjakob Furrer,Niels Obel,Enrico Girardi,(unknown),Marcelo H. Losso,Alejandro Arenas‐Pinto,Joan A. Caylà,Aza Rakhmanova,(unknown),(unknown),Jens Lundgren,Amanda Mocroft,Ole Kirk,(unknown)	25
12	Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients 2013 ·The International Journal of Tuberculosis and Lung Disease ·Daria Podlekareva,Daniel Grint,Frank A. Post,Amanda Mocroft,(unknown),Robert F. Miller,José M. Miró,Mathias Bruyand,Hansjakob Furrer,Vija Riekstiņa,Enrico Girardi,Marcelo H. Losso,Joan A. Caylà,(unknown),Niels Obel,(unknown),Jens Lundgren,Ole Kirk,(unknown)	8
13	Predicting the short‐term risk of diabetes in HIV‐positive patients: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study 2012 ·Journal of the International AIDS Society ·Kathy Petoumenos,Signe Westring Worm,Éric Fontas,Rainer Weber,Stéphane De Wit,Mathias Bruyand,Peter Reiss,Wafaa El‐Sadr,Antonella d’Arminio Monforte,Nina Friis‐Møller,Jens Lundgren,Matthew Law,(unknown)	53
14	Cognitive disorders in HIV-infected patients 2012 ·AIDS ·Fabrice Bonnet,Hélène Amieva,Fabienne Marquant,Charlotte Bernard,Mathias Bruyand,Frédéric‐Antoine Dauchy,P. Mercié,C. Greib,Laura Richert,D. Neau,Gwénaëlle Catheline,Patrick Dehail,François Dabis,Philippe Morlat,Jean‐François Dartigues,Geneviève Chêne	113
15	The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis 2011 ·HIV Medicine ·(unknown),Robert S. Hogg,(unknown),Margaret May,(unknown),Sophie Abgrall,Mathias Bruyand,Antonella d’Arminio Monforte,C. Tural,M. John Gill,(unknown),Peter Reiss,Amy C. Justice,Ole Kirk,Michael S Saag,Colette Smith,Rainer Weber,Jürgen K. Rockstroh,Pavel Khaykin,Jonathan A C Sterne	44
16	Information That Should Be Given to HIV Cohort Participants during Ongoing Research: The Viewpoints of Patient Representatives and Research Professionals 2011 ·Journal of Empirical Research on Human Research Ethics ·(unknown),Grégoire Moutel,F. Raffi,François Dabis,Mathias Bruyand,Christian Hervé,Catherine Leport,Nathalie Duchange	4
17	High frequency of poor locomotor performance in HIV-infected patients 2011 ·AIDS ·Laura Richert,Patrick Dehail,P. Mercié,Frédéric‐Antoine Dauchy,Mathias Bruyand,C. Greib,François Dabis,Fabrice Bonnet,Geneviève Chêne	63
18	High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome 2010 ·AIDS ·Signe Westring Worm,Nina Friis‐Møller,Mathias Bruyand,Antonella d’Arminio Monforte,Martin Rickenbach,Peter Reiss,Wafaa El‐Sadr,Andrew Phillips,Jens Lundgren,Caroline Sabin	67
19	Vaccination antiamarile : mise au point à propos des effets indésirables rares et graves 2009 ·Médecine et Maladies Infectieuses ·M. C. Receveur,Mathias Bruyand,Thierry Pistone,Denis Malvy	2
20	Vaccination contre la fièvre jaune en dehors des sujets immunocompétents 2008 ·Médecine et Maladies Infectieuses ·Mathias Bruyand,M. C. Receveur,Thierry Pistone,(unknown),Rodolphe Thiébaut,Denis Malvy	14

About Mathias Bruyand

Mathias Bruyand is a scholar working on Virology, Infectious Diseases and Endocrinology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (10 papers), HIV/AIDS Research and Interventions (10 papers) and HIV Research and Treatment (9 papers). The work is most often cited by research in Virology (278 citations), Endocrinology (188 citations) and Infectious Diseases (655 citations). Mathias Bruyand has collaborated with scholars based in France, Denmark and United Kingdom. Frequent co-authors include François Dabis, Geneviève Chêne, Fabrice Bonnet, Henriette de Valk, P. Mercié, Stéphane Bonacorsi, C. Greib, D. Neau, Jens Lundgren and Patricia Mariani‐Kurkdjian. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact